1200498-40-3

Basic information

• Product Name: Methyl 5-chloro-3-fluoropyridine-2-carboxylate
• Synonyms: Methyl 5-chloro-3-fluoropyridine-2-carboxylate;Methyl 5-chloro-3-fluoropicolinate;Methyl 5-chloro-3-fluoropicolinate, 5-Chloro-3-fluoro-2-(methoxycarbonyl)pyridine;5-Chloro-3-fluoro-pyridine-2-carboxylic acid methyl ester
• CAS NO: 1200498-40-3
• Molecular Formula: C7H5ClFNO2
• Molecular Weight: 189.5715032
• Mol File: 1200498-40-3.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Methyl 5-chloro-3-fluoropyridine-2-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 5-chloro-3-fluoropyridine-2-carboxylate(1200498-40-3)
• EPA Substance Registry System: Methyl 5-chloro-3-fluoropyridine-2-carboxylate(1200498-40-3)

Safety Data

• Hazardous Substances Data: 1200498-40-3(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Methyl 5-chloro-3-fluoropyridine-2-carboxylate is used as a key intermediate for the synthesis of various drugs and pharmaceuticals. Its unique structure and functional groups make it a valuable building block in the development of new medications with improved therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical sector, Methyl 5-chloro-3-fluoropyridine-2-carboxylate serves as an essential intermediate for the production of agricultural chemicals, including pesticides and herbicides. Its incorporation into these compounds enhances their effectiveness in controlling pests and weeds, thereby contributing to increased crop yields and food security.
Used in Research and Development:
Methyl 5-chloro-3-fluoropyridine-2-carboxylate is also utilized in the research and development of novel molecules for a wide range of applications. Its unique chemical properties and potential for modification make it an attractive candidate for the creation of new compounds with diverse functionalities and applications in various industries.

Upstream product

• 207994-08-9 5-chloro-3-fluoro-2-pyridinecarboxylic acid 
• 18107-18-1 diazomethyl-trimethyl-silane 
• 67-56-1 methanol 
• 89402-43-7 5-chloro-2,3-difluoropyridine 
• 514797-97-8 2-bromo-5-chloro-3-fluoro-pyridine 
• 514797-96-7 5-chloro-3-fluoropyridin-2-ol 
• 1200498-38-9 C₆H₂ClFNO₂^(1-)*Li⁽¹⁺⁾ 

Downstream Products

• 1200498-46-9 5-cyano-3-fluoropyridine-2-carboxylic acid 
• 214055-12-6 (5-chloro-3-fluoropyridin-2-yl)methanol 

Relevant articles and documents

NOVEL GALACTOSIDE INHIBITOR OF GALECTINS

The present invention relates to a compound of the general formula (I) wherein the pyranose ring is a-D-galactopyranose, R1 is selected from the group consisting of (II) wherein the asterix 1 * indicates the carbon atom of the heteroaromatic ring that is covalently attached to the triazole group of formula (I). The compound of formula (I) is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-1 to a ligand in a mammal, such as a human.

TRICYCLIC PIPERIDINE COMPOUNDS

The present invention relates to compounds of the formula (I) wherein R1a, R1b, R2, R3, (R4)n and ring (A) are as described in the description, to their preparation, to pharmaceutically acc

TRICYCLIC PIPERIDINE COMPOUNDS

The present invention relates to compounds of the formula (I), wherein R, R1a, R1b, R2, R3, and X are as described in the description, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), to methods for the preparation of such compounds of formula (I), and especially to their use as TPH modulators.

TRICYCLIC IMIDAZOLE COMPOUNDS AS INHIBITORS OF TRYPTOPHAN HYDROXYLASE

The present invention relates to compounds of the formula (I), wherein R1a, R1b, R2, R3, and X are as described in the description, to their preparation, to pharmaceutically acceptable salts thereof, and to thei

SULFUR-CONTAINING HETEROCYCLIC DERIVATIVE HAVING ?-SECRETASE-INHIBITING ACTIVITY

The following compound is provided as an agent for treating a disease induced by production, secretion and/or deposition of amyloid β protein, for example,. a compound represented by the formula (I): wherein ruing A is an optionally substituted carbocyclic group or an optionally substituted heterocyclic group, R1 is optionally substituted lower alkyl or the like, R2a and R2b are each independently hydrogen, optionally substituted lower alkyl or the like, R3a and R3c are each independently hydrogen, halogen, hydroxy, optionally substituted lower alkyl or the like, or a pharmaceutically acceptable salt thereof, or a solvate thereof.